Multi-cancer early detection blood test speeds up cancer diagnosis

A multi-cancer early detection test showed a positive predictive accuracy of 75% and negative predictive accuracy of 98% in a population referred for diagnostic follow-up after presenting to primary care with symptoms of cancer. The SYMPLIFY study, abstract 1501, presented in an oral abstract session at the ASCO 2023 Annual Meeting, also found that the

What Are Multi-Cancer Early Detection Tests and How Might They Impact the Future of Cancer Screening?

Ultrasensitive Blood Test Detects Multi-Cancer-Specific Biomarker

Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK

Multi-cancer blood test shows real promise in NHS study

Multi-cancer blood test shows real promise in NHS study

The Quest for Cancer-Detecting Blood Tests Speeds Up

Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect

New Tests and Devices for Early Cancer Detection - IEEE Pulse

Diagnostics, Free Full-Text